CareRx Corp provides pharmacy services to seniors living and other congregate care communities in Canada, including long-term care homes, retirement homes, assisted living facilities and group homes. Company news commonly covers financial results, dividends on common shares, conference calls, healthcare investor events and operating updates tied to medication management services.
CareRx's updates also describe its national network of pharmacy fulfillment centers, automated preparation and verification of multi-dose compliance packaging, and work with home operator partners on resident health, staff education and medication system quality and efficiency.
CareRx (CHHHF) declared a quarterly cash dividend of CAD $0.02 per common share, payable July 9, 2026, to shareholders of record at the close of business on June 23, 2026. The dividend is designated an eligible dividend for Canadian tax purposes; non‑residents may face withholding tax.
CareRx (OTC:CHHHF) reported Q1 2026 results: Average Beds Serviced rose to 92,036, revenue was CAD$93.9 million, and Adjusted EBITDA was CAD$8.4 million with a 9.0% margin. Cash from operations was CAD$6.9 million. The company estimates up to a CAD$2.0 million capitation reduction from changes to Ontario funding. Net debt declined to CAD$25.0 million. The board declared a CAD$0.02 dividend payable July 9, 2026. A Q1 results webcast and conference call are scheduled for May 7, 2026.
CareRx (OTC:CHHHF) will host a conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026 at 8:30 a.m. ET.
The company expects to report results for the period ended March 31, 2026, after market close on Wednesday, May 6, 2026. A live webcast and slide presentation will be available and archived for 90 days on the investor presentations page.
CareRx Corporation (TSX: CRRX / OTC: CHHHF) will participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference on April 21–22, 2026 at the Metro Toronto Convention Centre.
Management will hold investor meetings on April 21 and present on Wednesday, April 22 at 11:00 am ET. Registration is available via the conference link.
CareRx (OTC:CHHHF) declared a quarterly cash dividend of CAD$0.02 per common share, payable April 9, 2026, to shareholders of record at the close of business March 19, 2026. The dividend is designated an eligible dividend for Canadian tax purposes.
Dividends to non-residents are subject to withholding tax (may be reduced by treaty); U.S. taxation is governed by the Internal Revenue Code. Shareholders are advised to consult a tax advisor.
CareRx (CHHHF) reported 2025 results with revenue of $370.2M and adjusted EBITDA of $32.9M. The company delivered its first full year of positive net income of $26.1M, increased beds serviced, and declared a CAD$0.02 per‑share dividend payable April 9, 2026.
Average beds serviced rose to 92,250 in Q4 2025. Cash from operations for the year was $30.8M and net debt fell to $27.1M. The Board renewed an NCIB and cancelled 760,358 shares during 2025.
CareRx (TSX: CRRX / OTC: CHHHF) announced a CAD$0.02 per common share dividend, declared by the board on December 15, 2025. The dividend is payable on January 21, 2026 to holders of record at the close of business on December 23, 2025. The distribution is designated an eligible dividend for Canadian income tax purposes. The release notes that dividends to non-residents are subject to withholding tax (which may be reduced by treaty) and that U.S. taxation is governed by the Internal Revenue Code. Shareholders are advised to consult a tax advisor for personal tax consequences.
CareRx (CHHHF) will host a conference call to discuss its third quarter 2025 financial results on Tuesday, November 4, 2025 at 8:30 a.m. ET. The company expects to report results for the period ended September 30, 2025 after market close on Monday, November 3, 2025.
Telephone dial-in access: 647-849-3320 or 1-833-752-4643 (connect ~15 minutes early). A live webcast and slide presentation will be available on the Investors > Events and Presentations page at https://carerx.ca/presentations/. The webcast and slides will be archived for 90 days.
CareRx Corporation (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, has announced the initiation of a quarterly dividend program. The company's Board of Directors has declared a dividend of $0.02 per Common Share, payable on October 15, 2025, to shareholders of record as of September 23, 2025.
According to CEO Puneet Khanna, this initiative reflects the company's strong cash generation capabilities and disciplined capital allocation strategy. CareRx remains committed to investing in both organic and inorganic growth initiatives while maintaining financial flexibility.
CareRx Corporation (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, reported Q2 2025 financial results. Revenue reached $91.4 million, up from Q1 2025's $89.6 million but slightly down from Q2 2024's $92.0 million. The company achieved net income of $0.6 million, improving from $0.2 million in Q1 2025 and reversing a $1.4 million loss from Q2 2024.
Notably, Adjusted EBITDA grew to $8.0 million (8.8% margin), showing improvement from both Q1 2025 ($7.8 million) and Q2 2024 ($7.5 million). The company's bed count reached 91,062, marking the start of an expected growth period. Additionally, the Ontario Ministry of Health paused previously scheduled reductions in long-term care pharmacy funding fees, which would have decreased from $1,500 to $1,200 per bed annually.